Overview: Leptospira IgM ICT TestIntroduction: The Leptospira IgM ICT Test detects Leptospira IgM via rapid test to diagnose leptospirosis, causing fever or organ damage. Following 2023 WHO guidelines, it uses immunochromatographic testing (ICT) for high specificity, supporting parasite screening. This test is critical for guiding rapid diagnosis, treatment planning, and improving outcomes in parasitology for patients with suspected acute leptospirosis.
Other Names: Leptospira IgM Rapid Assay, Leptospirosis ICT Test.
FDA Status: Laboratory-developed test (LDT), meeting parasitology standards for diagnostic accuracy.
Historical Milestone: Leptospira ICT testing emerged in the 2000s with rapid diagnostic research. ICT methods improved accessibility in resource-limited settings.
Purpose: Detects Leptospira IgM via rapid test to diagnose leptospirosis, guides treatment, and evaluates patients with fever or organ damage.
Test Parameters: 1. Leptospira IgM Antibodies (ICT)
Pretest Condition: No fasting required. Collect serum or saliva. Report history of fever, organ damage, or exposure to contaminated water.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fever, organ damage, jaundice, or exposure to contaminated water or animals. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, leptospirosis implications, and risks of blood or saliva collection.
Procedural Considerations: Uses rapid immunochromatographic testing to detect Leptospira IgM in serum or saliva. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for acute leptospirosis diagnosis.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Early infection may yield false negatives.
Clinical Significance: Positive Leptospira IgM confirms recent leptospirosis, guiding antibiotic therapy. Negative results may require PCR or further testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: Leptospira PCR, IgG test, or blood-culture to confirm leptospirosis diagnosis.
Test Limitations: Rapid test may miss early infection; clinical correlation is needed. Cross-reactivity with other spirochetes may occur.
References: WHO Leptospirosis Guidelines, 2023; Clinical Infectious Diseases, Levett PN, 2022.
